Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197

References

• Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5:685 - 94; http://dx.doi.org/10.1016/S1473-3099(05)70267-X; PMID: 16253886
   PubMed Web of Science ®Google Scholar
• Fischetti VA, Hodges WM, Hruby DE. Protection against streptococcal pharyngeal colonization with a vaccinia: M protein recombinant. Science 1989; 244:1487 - 90; http://dx.doi.org/10.1126/science.2660266; PMID: 2660266
   PubMed Web of Science ®Google Scholar
• Lancefield RC, Perlmann GE. Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus. J Exp Med 1952; 96:71 - 82; http://dx.doi.org/10.1084/jem.96.1.71; PMID: 14946330
   PubMed Web of Science ®Google Scholar
• McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, et al. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 2005; 41:1114 - 22; http://dx.doi.org/10.1086/444458; PMID: 16163629
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Wotton JT, Johnson DR. Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis. Lancet 2001; 358:1334 - 7; http://dx.doi.org/10.1016/S0140-6736(01)06415-7; PMID: 11684215
   PubMed Web of Science ®Google Scholar
• Tewodros W, Kronvall G. M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns. J Clin Microbiol 2005; 43:4369 - 76; http://dx.doi.org/10.1128/JCM.43.9.4369-4376.2005; PMID: 16145079
   PubMed Web of Science ®Google Scholar
• Dale JB, Penfound TA, Chiang EY, Walton WJ. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine 2011; 29:8175 - 8; http://dx.doi.org/10.1016/j.vaccine.2011.09.005; PMID: 21920403
   PubMed Web of Science ®Google Scholar
• Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 2009; 9:611 - 6; http://dx.doi.org/10.1016/S1473-3099(09)70178-1; PMID: 19778763
   PubMed Web of Science ®Google Scholar
• Bessen D, Fischetti VA. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol 1990; 145:1251 - 6; PMID: 1696296
   PubMed Web of Science ®Google Scholar
• Guilherme L, Faé KC, Higa F, Chaves L, Oshiro SE, Freschi de Barros S, et al. Towards a vaccine against rheumatic fever. Clin Dev Immunol 2006; 13:125 - 32; http://dx.doi.org/10.1080/17402520600877026; PMID: 17162355
   PubMed Web of Science ®Google Scholar
• Pruksakorn S, Currie B, Brandt E, Martin D, Galbraith A, Phornphutkul C, et al. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Lancet 1994; 344:639 - 42; http://dx.doi.org/10.1016/S0140-6736(94)92083-4; PMID: 7520963
   PubMed Web of Science ®Google Scholar
• Pruksakorn S, Galbraith A, Houghten RA, Good MF. Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies. J Immunol 1992; 149:2729 - 35; PMID: 1383324
   PubMed Web of Science ®Google Scholar
• Relf WA, Cooper J, Brandt ER, Hayman WA, Anders RF, Pruksakorn S, et al. Mapping a conserved conformational epitope from the M protein of group A streptococci. Pept Res 1996; 9:12 - 20; PMID: 8727479
   PubMedGoogle Scholar
• Hayman WA, Brandt ER, Relf WA, Cooper J, Saul A, Good MF. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Int Immunol 1997; 9:1723 - 33; http://dx.doi.org/10.1093/intimm/9.11.1723; PMID: 9418133
   PubMed Web of Science ®Google Scholar
• Batzloff MR, Hayman WA, Davies MR, Zeng M, Pruksakorn S, Brandt ER, et al. Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection. J Infect Dis 2003; 187:1598 - 608; http://dx.doi.org/10.1086/374800; PMID: 12721940
   PubMed Web of Science ®Google Scholar
• Brandt ER, Sriprakash KS, Hobb RI, Hayman WA, Zeng W, Batzloff MR, et al. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat Med 2000; 6:455 - 9; http://dx.doi.org/10.1038/74719; PMID: 10742155
   PubMed Web of Science ®Google Scholar
• Shinefield HR. Overview of the development and current use of CRM(197) conjugate vaccines for pediatric use. Vaccine 2010; 28:4335 - 9; http://dx.doi.org/10.1016/j.vaccine.2010.04.072; PMID: 20452430
   PubMed Web of Science ®Google Scholar
• Bisno AL, Rubin FA, Cleary PP, Dale JB, National Institute of Allergy and Infectious Diseases. Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop. Clin Infect Dis 2005; 41:1150 - 6; http://dx.doi.org/10.1086/444505; PMID: 16163634
   PubMed Web of Science ®Google Scholar
• Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med 2002; 346:1200 - 6; http://dx.doi.org/10.1056/NEJMoa013169; PMID: 11961148
   PubMed Web of Science ®Google Scholar
• Richter SS, Heilmann KP, Dohrn CL, Beekmann SE, Riahi F, Garcia-de-Lomas J, et al. Increasing telithromycin resistance among Streptococcus pyogenes in Europe. J Antimicrob Chemother 2008; 61:603 - 11; http://dx.doi.org/10.1093/jac/dkm525; PMID: 18218647
   PubMed Web of Science ®Google Scholar
• Bisno AL, Gerber MA, Gwaltney JM Jr., Kaplan EL, Schwartz RH, Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002; 35:113 - 25; http://dx.doi.org/10.1086/340949; PMID: 12087516
   PubMed Web of Science ®Google Scholar
• Fischetti VA, Windels M. Mapping the immunodeterminants of the complete streptococcal M6 protein molecule. Identification of an immunodominant region. J Immunol 1988; 141:3592 - 9; PMID: 2460540
   PubMed Web of Science ®Google Scholar
• Guilherme L, Postol E, Freschi de Barros S, Higa F, Alencar R, Lastre M, et al. A vaccine against S. pyogenes: design and experimental immune response. Methods 2009; 49:316 - 21; http://dx.doi.org/10.1016/j.ymeth.2009.03.024; PMID: 19409999
   PubMed Web of Science ®Google Scholar
• Batzloff MYH, Yan H, Davies M, Hartas J, Good M. Preclinical evaluation of a vaccine based on conserved region of M protein that prevents group A streptococcal infection. Indian J Med Res 2004; 119:Suppl 104 - 7; PMID: 15232173
   PubMed Web of Science ®Google Scholar
• Olive C, Clair T, Yarwood P, Good MF. Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope. Vaccine 2002; 20:2816 - 25; http://dx.doi.org/10.1016/S0264-410X(02)00205-0; PMID: 12034109
   PubMed Web of Science ®Google Scholar
• Kabanova A, Margarit I, Berti F, Romano MR, Grandi G, Bensi G, et al. Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate. Vaccine 2010; 29:104 - 14; http://dx.doi.org/10.1016/j.vaccine.2010.09.018; PMID: 20870056
   PubMed Web of Science ®Google Scholar
• Knudsen JD, Frimodt-Møller N, Espersen F. Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother 1995; 39:1253 - 8; http://dx.doi.org/10.1128/AAC.39.6.1253; PMID: 7574511
   PubMed Web of Science ®Google Scholar
• Skinner JM, Caro-Aguilar IC, Payne AM, Indrawati L, Fontenot J, Heinrichs JH. Comparison of rhesus and cynomolgus macaques in a Streptococcus pyogenes infection model for vaccine evaluation. Microb Pathog 2011; 50:39 - 47; http://dx.doi.org/10.1016/j.micpath.2010.10.004; PMID: 21035535
   PubMed Web of Science ®Google Scholar
• Sandin C, Carlsson F, Lindahl G. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes. Mol Microbiol 2006; 59:20 - 30; http://dx.doi.org/10.1111/j.1365-2958.2005.04913.x; PMID: 16359315
   PubMed Web of Science ®Google Scholar
• García A, Paul K, Beall B, McClure H. Toxic shock due to Streptococcus pyogenes in a rhesus monkey (Macaca mulatta). J Am Assoc Lab Anim Sci 2006; 45:79 - 82; PMID: 16995651
   PubMed Web of Science ®Google Scholar
• Seegal B, Heller G, Jablonowitz J. Incidence of Hemolytic Streptococci and Pneumococci in the Pharyngeal Flora of Normal Rhesus Monkeys. Proc Soc Exp Biol Med 1936; 34:812 - 6
   Google Scholar
• Hermanson GT. Bioconjugate Techniques. London: Academic Press, 2008.
   Google Scholar
• Nahas DD, Palladino JS, Joyce JG, Hepler RW. Amino acid analysis of peptide loading ratios in conjugate vaccines: a comparison of direct electrochemical detection and 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate pre-column derivatization methods. Bioconjug Chem 2008; 19:322 - 6; http://dx.doi.org/10.1021/bc700232z; PMID: 18072716
   PubMed Web of Science ®Google Scholar
• Siegert J, Sastalla I, Chhatwal GS, Medina E. Vaccination equally enables both genetically susceptible and resistant mice to control infection with group A streptococci. Microbes Infect 2006; 8:347 - 53; http://dx.doi.org/10.1016/j.micinf.2005.06.024; PMID: 16213175
   PubMed Web of Science ®Google Scholar
• Olive C, Ho MF, Dyer J, Lincoln D, Barozzi N, Toth I, et al. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis 2006; 193:1666 - 76; http://dx.doi.org/10.1086/504266; PMID: 16703510
   PubMed Web of Science ®Google Scholar
• Olive C, Batzloff MR, Horváth A, Wong A, Clair T, Yarwood P, et al. A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies. Infect Immun 2002; 70:2734 - 8; http://dx.doi.org/10.1128/IAI.70.5.2734-2738.2002; PMID: 11953422
   PubMed Web of Science ®Google Scholar
• Sumby P, Tart AH, Musser JM. A Non-Human Primate Model of Acute Group A Streptococcus Pharyngitis. In: Otto FDaM, ed. Methods in Molecular Biology. Totowa, NJ: Humana Press, 2006:255-67.
   Google Scholar